Tag Archives: 2012 BIO International Convention

Monday Items for #BIO2012 Business Forum

partnering-logo-btn

Happy Monday Everyone! We thought we would do a quick post on some important items concerning the BIO Business Forum and One-on-One Partnering. The Profile Publication Deadline is May 22nd. Why is this important? For one, if you have not published your profile, companies just have a harder time finding you. Make it easy for them. Fill out your keywords; provide as much detail in the assets/products/services categories as possible; Publish and Save! Second, publishing Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Announcing the Buzz of BIO Winner for Pipelines of Promise!

BuzzofBIOLogo

We’re very pleased to announce the Buzz of BIO Winner for the 2012 contest of the BIO International Convention. You voted for your favorites, and it was a tight, interesting race! As such, we’re pleased to introduce you to our winner for the Pipelines of Promise category. Deuteria Pharmaceuticals, Inc,. who focuses on improving the product profile of approved drugs through ‘chiral switching’, won the Pipelines of Promise category. From Dr. Sheila DeWitt, the company’s Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

myBIO and One-on-One Partnering… What’s the Difference?

This June, thousands will gather in the biotech hub of Boston! One of the things the team has been hard at work on, is the online community of myBIO, as those who have attended the Convention in the past will recognize. It’s a very handy, interactive tool that allows you to track companies, communicate with other attendees, and get a bird’s-eye view of all the different events going on. As a registrant, you even have Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Industry Regulatory Issues to be Highlighted at 2012 BIO International Convention

bio-session

In the words of BIO’s Andrew Emmett, Managing Director, Science & Regulatory Affairs, ‘2012 is shaping up to be a momentous year for FDA reform.’ From the reauthorization of the Prescription Drug User Fee Act (PDUFA V) to modernizing and expediting the approval of new drugs and biologics, implementing the new biosimilars pathways and addressing the growing global drug shortage crisis, all eyes are on the current regulatory environment and its role in supporting innovation. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Convention 2012: Biotech IP and Tech Transfer Sessions

US PTO

Recent court decisions and ongoing implementation of the America Invents Act are certain to impact the life sciences industry. The 2012 BIO International Convention will feature an educational track devoted to Biotech Patenting and Tech Transfer to discuss legal and legislative developments and how they are likely to impact biotech companies.   This year’s global event for biotechnology will take place June 18-21, 2012 at the Boston Convention and Exhibition Center in Boston, MA. Recent Developments Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , ,